640 filings
Page 10 of 32
D
xyh8xr pgpodijo8
17 Sep 19
$19.52M in options, sold $19.52M, 1 investor
8:31am
8-K
tve0dy
13 Sep 19
Entry into a Material Definitive Agreement
9:01am
D
jxkho q9vp
9 Aug 19
$105.11M in options, sold $105.11M, 5 investors
4:26pm
8-K
01iql gbo11uo0d
8 Aug 19
Ziopharm Oncology Reports Second Quarter 2019
8:00am
8-K
o4hpmc3re6ur1fr f8ex
1 Aug 19
Ziopharm Oncology Announces $45 Million
4:31pm
8-K
bywhbvcvjrvlrl59s 6o
24 Jul 19
Unregistered Sales of Equity Securities
8:39am
8-K
djliqejacp n8pl3j1
3 Jul 19
Ziopharm Oncology Names NCI’s Dr. Drew Deniger to
8:42am
8-K
9plx7rjgu 77244ra5s0
27 Jun 19
Regulation FD Disclosure
4:31pm
8-K
yvso8gg6bekkw7da9c
26 Jun 19
Regulation FD Disclosure
8:35am
S-3ASR
2dsg ag5bojkp3g
21 Jun 19
Automatic shelf registration
5:31pm
8-K
4hwfiiqlfvkmh5qxa
17 Jun 19
Departure of Directors or Certain Officers
4:31pm
8-K
y3w2vo c0t
28 May 19
Entry into a Material Definitive Agreement
4:26pm
8-K
8wbph
8 May 19
Ziopharm Oncology Reports First Quarter 2019 Financial Results and Reaffirms Clinical Timelines
4:11pm
8-K
icisz njj
29 Apr 19
Departure of Directors or Certain Officers
4:42pm
DEFA14A
4euc0v
29 Apr 19
Additional proxy soliciting materials
4:38pm
8-K
4r5rdiuofuc9lk
5 Mar 19
Ziopharm Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
4:10pm